Clinical validity of presynaptic dopaminergic imaging withÂ 123I-ioflupaneÂ and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development

Article ID	Journal	Published Year	Pages	File Type
4932762	Neurobiology of Aging	2017	15 Pages	PDF

Keywords

Biomarker-based diagnosis 123I-MIBG Alzheimer's disease Differential diagnosis DLB, Dementia with Lewy bodies

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Ageing

Preview

Clinical validity of presynaptic dopaminergic imaging withÂ 123I-ioflupaneÂ and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development

Authors

Ida Sonni, Osman Ratib, Marina Boccardi, Agnese Picco, Karl Herholz, Flavio Nobili, Andrea Varrone, Geneva Task Force for the Roadmap of Alzheimer's Biomarkers Geneva Task Force for the Roadmap of Alzheimer's Biomarkers,